2
Van Kerkhove, M. D., Bento, A. I., Mills, H. L., Ferguson, N. M., & Donnelly, C. A. (2015). A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making. Scientific Data, 2(1). doi:10.1038/sdata.2015.19


3
Van Kerkhove, M. D., Bento, A. I., Mills, H. L., Ferguson, N. M., & Donnelly, C. A. (2015). A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making. Scientific Data, 2(1). doi:10.1038/sdata.2015.19


4
Van Kerkhove, M. D., Bento, A. I., Mills, H. L., Ferguson, N. M., & Donnelly, C. A. (2015). A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making. Scientific Data, 2(1). doi:10.1038/sdata.2015.19


5
Van Kerkhove, M. D., Bento, A. I., Mills, H. L., Ferguson, N. M., & Donnelly, C. A. (2015). A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making. Scientific Data, 2(1). doi:10.1038/sdata.2015.19


6
Van Kerkhove, M. D., Bento, A. I., Mills, H. L., Ferguson, N. M., & Donnelly, C. A. (2015). A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making. Scientific Data, 2(1). doi:10.1038/sdata.2015.19


7
Van Kerkhove, M. D., Bento, A. I., Mills, H. L., Ferguson, N. M., & Donnelly, C. A. (2015). A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making. Scientific Data, 2(1). doi:10.1038/sdata.2015.19


8
Pavlin, B. I. (2014). Calculation of incubation period and serial interval from multiple outbreaks of Marburg virus disease. BMC Research Notes, 7(1), 906. doi:10.1186/1756-0500-7-906


9
Shifflett, K., & Marzi, A. (2019). Marburg virus pathogenesis – differences and similarities in humans and animal models. Virology Journal, 16(1). doi:10.1186/s12985-019-1272-z


10
Van Kerkhove, M. D., Bento, A. I., Mills, H. L., Ferguson, N. M., & Donnelly, C. A. (2015). A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making. Scientific Data, 2(1). doi:10.1038/sdata.2015.19


11
Singh, A., Singh, R. S., Sarma, P., Batra, G., Joshi, R., Kaur, H., … Medhi, B. (2020). A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV. Virologica Sinica, 35(3), 290–304. doi:10.1007/s12250-020-00252-z


12
Singh, A., Singh, R. S., Sarma, P., Batra, G., Joshi, R., Kaur, H., … Medhi, B. (2020). A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV. Virologica Sinica, 35(3), 290–304. doi:10.1007/s12250-020-00252-z


13
Singh, A., Singh, R. S., Sarma, P., Batra, G., Joshi, R., Kaur, H., … Medhi, B. (2020). A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV. Virologica Sinica, 35(3), 290–304. doi:10.1007/s12250-020-00252-z


14
Shamim, S., Khan, M., Kharaba, Z. J., Ijaz, M., & Murtaza, G. (2020). Potential strategies for combating COVID-19. Archives of Virology, 165(11), 2419–2438. doi:10.1007/s00705-020-04768-3


15
Da Costa, V. G., Moreli, M. L., & Saivish, M. V. (2020). The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century. Archives of Virology, 165(7), 1517–1526. doi:10.1007/s00705-020-04628-0


16
Da Costa, V. G., Moreli, M. L., & Saivish, M. V. (2020). The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century. Archives of Virology, 165(7), 1517–1526. doi:10.1007/s00705-020-04628-0


17
Da Costa, V. G., Moreli, M. L., & Saivish, M. V. (2020). The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century. Archives of Virology, 165(7), 1517–1526. doi:10.1007/s00705-020-04628-0


18
Da Costa, V. G., Moreli, M. L., & Saivish, M. V. (2020). The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century. Archives of Virology, 165(7), 1517–1526. doi:10.1007/s00705-020-04628-0


19
Assiri, A., McGeer, A., Perl, T. M., Price, C. S., Al Rabeeah, A. A., Cummings, D. A. T., … Memish, Z. A. (2013). Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus. New England Journal of Medicine, 369(5), 407–416. doi:10.1056/nejmoa1306742


20
Mizumoto, K., Endo, A., Chowell, G., Miyamatsu, Y., Saitoh, M., & Nishiura, H. (2015). Real-time characterization of risks of death associated with the Middle East respiratory syndrome (MERS) in the Republic of Korea, 2015. BMC Medicine, 13(1). doi:10.1186/s12916-015-0468-3


21
Da Costa, V. G., Moreli, M. L., & Saivish, M. V. (2020). The emergence of SARS, MERS and novel SARS-2 coronaviruses in the 21st century. Archives of Virology, 165(7), 1517–1526. doi:10.1007/s00705-020-04628-0


22
Antiochia, R. (2020). Nanobiosensors as new diagnostic tools for SARS, MERS and COVID-19: from past to perspectives. Microchimica Acta, 187(12). doi:10.1007/s00604-020-04615-x


23
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020). SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDisease. doi:10.1007/s13337-020-00632-9


24
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020). SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDisease. doi:10.1007/s13337-020-00632-9


25
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020). SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDisease. doi:10.1007/s13337-020-00632-9


26
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020). SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDisease. doi:10.1007/s13337-020-00632-9


27
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020). SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDisease. doi:10.1007/s13337-020-00632-9


28
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020). SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDisease. doi:10.1007/s13337-020-00632-9


29
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020). SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDisease. doi:10.1007/s13337-020-00632-9


30
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020). SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDisease. doi:10.1007/s13337-020-00632-9


31
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020). SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDisease. doi:10.1007/s13337-020-00632-9


32
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020). SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDisease. doi:10.1007/s13337-020-00632-9


33
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020). SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDisease. doi:10.1007/s13337-020-00632-9


34
Krishnamoorthy, S., Swain, B., Verma, R. S., & Gunthe, S. S. (2020). SARS-CoV, MERS-CoV, and 2019-nCoV viruses: an overview of origin, evolution, and genetic variations. VirusDisease. doi:10.1007/s13337-020-00632-9


35
Gikonyo, S., Kimani, T., Matere, J., Kimutai, J., Kiambi, S. G., Bitek, A. O., … Fasina, F. O. (2018). Mapping Potential Amplification and Transmission Hotspots for MERS-CoV, Kenya. EcoHealth, 15(2), 372–387. doi:10.1007/s10393-018-1317-6


36
Prescott, J., de Wit, E., Feldmann, H., & Munster, V. J. (2012). The immune response to Nipah virus infection. Archives of Virology, 157(9), 1635–1641. doi:10.1007/s00705-012-1352-5


37
Wacharapluesadee, S., Samseeneam, P., Phermpool, M., Kaewpom, T., Rodpan, A., Maneeorn, P., … Hemachudha, T. (2016). Molecular characterization of Nipah virus from Pteropus hypomelanus in Southern Thailand. Virology Journal, 13(1). doi:10.1186/s12985-016-0510-x


38
Chua, K. B. (2003). Nipah virus outbreak in Malaysia. Journal of Clinical Virology, 26(3), 265–275. doi:10.1016/s1386-6532(02)00268-8


39
Murray, K., Rogers, R., Selvey, L., Selleck, P., Hyatt, A., Gould, A., … Westbury, H. (1995). A Novel Morbillivirus Pneumonia of Horses and its Transmission to Humans. Emerging Infectious Diseases, 1(1), 31–33. doi:10.3201/eid0101.950107


40
Halpin, K., Young, P. L., Field, H. E., & Mackenzie, J. S. (2000). Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. Journal of General Virology, 81(8), 1927–1932. doi:10.1099/0022-1317-81-8-1927


41
Meagher, K. E., & Decker, C. F. (2012). Other Tick-Borne Illnesses: Tularemia, Colorado Tick Fever, Tick Paralysis. Disease-a-Month, 58(6), 370–376. doi:10.1016/j.disamonth.2012.03.010


42
Dawes, B. E., Gao, J., Atkins, C., Nelson, J. T., Johnson, K., Wu, P., & Freiberg, A. N. (2018). Human neural stem cell-derived neuron/astrocyte co-cultures respond to La Crosse virus infection with proinflammatory cytokines and chemokines. Journal of Neuroinflammation, 15(1). doi:10.1186/s12974-018-1356-5


43
Yang, F., Chan, K., Brewster, C. C., & Paulson, S. L. (2019). Effects of La Crosse virus infection on the host-seeking behavior and levels of two neurotransmitters in Aedes triseriatus. Parasites & Vectors, 12(1). doi:10.1186/s13071-019-3658-6


44
Eastwood, G., Shepard, J. J., Misencik, M. J., Andreadis, T. G., & Armstrong, P. M. (2020). Local persistence of novel regional variants of La Crosse virus in the Northeast USA. Parasites & Vectors, 13(1). doi:10.1186/s13071-020-04440-4


45
Eastwood, G., Shepard, J. J., Misencik, M. J., Andreadis, T. G., & Armstrong, P. M. (2020). Local persistence of novel regional variants of La Crosse virus in the Northeast USA. Parasites & Vectors, 13(1). doi:10.1186/s13071-020-04440-4


46
Eastwood, G., Shepard, J. J., Misencik, M. J., Andreadis, T. G., & Armstrong, P. M. (2020). Local persistence of novel regional variants of La Crosse virus in the Northeast USA. Parasites & Vectors, 13(1). doi:10.1186/s13071-020-04440-4


47
Haddow, A. D., Bixler, D., & Odoi, A. (2011). The spatial epidemiology and clinical features of reported cases of La Crosse Virus infection in West Virginia from 2003 to 2007. BMC Infectious Diseases, 11(1). doi:10.1186/1471-2334-11-29


48
Haddow, A. D., Bixler, D., & Odoi, A. (2011). The spatial epidemiology and clinical features of reported cases of La Crosse Virus infection in West Virginia from 2003 to 2007. BMC Infectious Diseases, 11(1). doi:10.1186/1471-2334-11-29


49
Haddow, A. D., Bixler, D., & Odoi, A. (2011). The spatial epidemiology and clinical features of reported cases of La Crosse Virus infection in West Virginia from 2003 to 2007. BMC Infectious Diseases, 11(1). doi:10.1186/1471-2334-11-29


50
Bennett, R. S., Cress, C. M., Ward, J. M., Firestone, C.-Y., Murphy, B. R., & Whitehead, S. S. (2008). La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys. Virology Journal, 5(1), 25. doi:10.1186/1743-422x-5-25


51
Gaensbauer, J. T., Lindsey, N. P., Messacar, K., Staples, J. E., & Fischer, M. (2014). Neuroinvasive Arboviral Disease in the United States: 2003 to 2012. PEDIATRICS, 134(3), e642–e650. doi:10.1542/peds.2014-0498


52
Gaensbauer, J. T., Lindsey, N. P., Messacar, K., Staples, J. E., & Fischer, M. (2014). Neuroinvasive Arboviral Disease in the United States: 2003 to 2012. PEDIATRICS, 134(3), e642–e650. doi:10.1542/peds.2014-0498


53
Gaensbauer, J. T., Lindsey, N. P., Messacar, K., Staples, J. E., & Fischer, M. (2014). Neuroinvasive Arboviral Disease in the United States: 2003 to 2012. PEDIATRICS, 134(3), e642–e650. doi:10.1542/peds.2014-0498


54
Gaensbauer, J. T., Lindsey, N. P., Messacar, K., Staples, J. E., & Fischer, M. (2014). Neuroinvasive Arboviral Disease in the United States: 2003 to 2012. PEDIATRICS, 134(3), e642–e650. doi:10.1542/peds.2014-0498


55
Gaensbauer, J. T., Lindsey, N. P., Messacar, K., Staples, J. E., & Fischer, M. (2014). Neuroinvasive Arboviral Disease in the United States: 2003 to 2012. PEDIATRICS, 134(3), e642–e650. doi:10.1542/peds.2014-0498


56
Oliver, J., Lukacik, G., Kokas, J., Campbell, S. R., Kramer, L. D., Sherwood, J. A., & Howard, J. J. (2018). Twenty years of surveillance for Eastern equine encephalitis virus in mosquitoes in New York State from 1993 to 2012. Parasites & Vectors, 11(1). doi:10.1186/s13071-018-2950-1


57
Vander Kelen, P. T., Downs, J. A., Stark, L. M., Loraamm, R. W., Anderson, J. H., & Unnasch, T. R. (2012). Spatial epidemiology of eastern equine encephalitis in Florida. International Journal of Health Geographics, 11(1), 47. doi:10.1186/1476-072x-11-47


58
Jacob, B. G., Burkett-Cadena, N. D., Luvall, J. C., Parcak, S. H., McClure, C. J., Estep, L. K., … Unnasch, T. R. (2010). Developing GIS-based eastern equine encephalitis vector-host models in Tuskegee, Alabama. International Journal of Health Geographics, 9(1), 12. doi:10.1186/1476-072x-9-12


59
Roy, C. J., Reed, D. S., Wilhelmsen, C. L., Hartings, J., Norris, S., & Steele, K. E. (2009). Pathogenesis of aerosolized Eastern Equine Encephalitis virus infection in guinea pigs. Virology Journal, 6(1). doi:10.1186/1743-422x-6-170


